Ito H - Search Results

1

Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).

Ito H, Harano Y, Suzuki M, Hattori Y, Takeuchi M, Inada H, Inoue J, Kawamori R, Murase T, Ouchi Y, Umeda F, Nawata H, Orimo H. Ito H, et al. Diabetes. 1996 Jul;45 Suppl 3:S19-23. doi: 10.2337/diab.45.3.s19. Diabetes. 1996. PMID: 8674883

2

Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus.

Araki A, Ito H, Hattori A, Inoue J, Sato T, Shiraki M, Orimo H. Araki A, et al. Among authors: ito h. Diabetes Care. 1993 Aug;16(8):1184-6. doi: 10.2337/diacare.16.8.1184. Diabetes Care. 1993. PMID: 8375248

3

Clinical implication of multiple risk factor control in the management of diabetic macrovasucular complications.

Suzuki M, Hattori Y, Takeuchi M, Kimura Y, Yamazaki Y, Inada H, Murase O, Ito H, Nawata H, Orimo H, Harano Y; MSDM Group. Multiclinical Study for Diabetic Macroangiopathy. Suzuki M, et al. Among authors: ito h. J Diabetes Complications. 2002 Jan-Feb;16(1):115-8. doi: 10.1016/s1056-8727(01)00205-7. J Diabetes Complications. 2002. PMID: 11872378

4

Evening primrose oil and fish oil in non-insulin-dependent-diabetes.

Takahashi R, Inoue J, Ito H, Hibino H. Takahashi R, et al. Among authors: ito h. Prostaglandins Leukot Essent Fatty Acids. 1993 Aug;49(2):569-71. doi: 10.1016/0952-3278(93)90162-p. Prostaglandins Leukot Essent Fatty Acids. 1993. PMID: 8415806 Clinical Trial.

5

[Lipoprotein(a) as a risk factor for cardiovascular disease in elderly patients with diabetes].

Miyao M, Araki A, Hattori A, Miyachi T, Inoue J, Horiuchi T, Nakamura T, Ueda S, Nakahara K, Matsushita S, Ito H. Miyao M, et al. Among authors: ito h. Nihon Ronen Igakkai Zasshi. 1997 Mar;34(3):185-91. doi: 10.3143/geriatrics.34.185. Nihon Ronen Igakkai Zasshi. 1997. PMID: 9155192 Free article. Japanese.

6

A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE).

Ito H, Ouchi Y, Ohashi Y, Saito Y, Ishikawa T, Nakamura H, Orimo H. Ito H, et al. J Atheroscler Thromb. 2001;8(2):33-44. doi: 10.5551/jat1994.8.33. J Atheroscler Thromb. 2001. PMID: 11770708 Clinical Trial.

7

Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.

Kazama H, Usui S, Okazaki M, Hosoi T, Ito H, Orimo H. Kazama H, et al. Among authors: ito h. Diabetes Res Clin Pract. 2003 Mar;59(3):181-9. doi: 10.1016/s0168-8227(02)00243-7. Diabetes Res Clin Pract. 2003. PMID: 12590014 Clinical Trial.

8

[The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].

Shiraki M, Ito H, Orimo H. Shiraki M, et al. Among authors: ito h. Nihon Naibunpi Gakkai Zasshi. 1989 Nov 20;65(11):1253-63. doi: 10.1507/endocrine1927.65.11_1253. Nihon Naibunpi Gakkai Zasshi. 1989. PMID: 2591609 Japanese.

9

The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3.

Shiraki M, Ito H, Orimo H. Shiraki M, et al. Among authors: ito h. Bone Miner. 1993 Mar;20(3):223-34. doi: 10.1016/s0169-6009(08)80003-7. Bone Miner. 1993. PMID: 8490326

10

[Bone mineral density in postmenopausal elderly women with type 2 diabetes].

Horiuchi T, Nakamura T, Miyao M, Inoue J, Hattori A, Araki A, Shiraki M, Ito H. Horiuchi T, et al. Among authors: ito h. Nihon Ronen Igakkai Zasshi. 1995 Nov;32(11):756-60. doi: 10.3143/geriatrics.32.756. Nihon Ronen Igakkai Zasshi. 1995. PMID: 8598632 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,398 results

Search Page

Filters